K31.A14
Gastric intestinal metaplasia without dysplasia, involving the cardia
Clinical Classification Guidelines
Medical Intelligence & Overview
Gastric intestinal metaplasia (IM) without dysplasia involving the cardia is a condition characterized by the transformation of the stomach's lining cells into a type resembling intestinal tissue. This change occurs specifically in the area where the stomach connects to the esophagus, called the cardia. While this condition is not cancerous, it's considered a precancerous state that warrants careful medical evaluation and monitoring. Recognizing and understanding this condition can help patients collaborate effectively with healthcare providers for management and prevention of potential complications.
Causes & Symptoms
Clinical Causes: Chronic gastritis, especially due to infection with Helicobacter pylori bacteria Long-term acid reflux or gastroesophageal reflux disease (GERD) Lifestyle factors such as smoking and excessive alcohol consumption Dietary influences, including high salt intake or consumption of smoked foods Autoimmune gastric conditions Genetic predisposition
Key Symptoms: Often asymptomatic and discovered incidentally during endoscopy Indigestion or symptoms similar to gastritis Mild abdominal discomfort or pain Feeling of fullness after eating small meals Nausea or occasional vomiting Potential bleeding leading to anemia in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves an upper gastrointestinal endoscopy where tissue samples, or biopsies, are taken from the stomach's lining near the cardia. These samples are examined under a microscope to detect intestinal metaplasia. Additional tests such as histopathology, Helicobacter pylori testing, and imaging studies may be performed to assess the extent and nature of the gastric tissue changes. Regular monitoring through endoscopy is often recommended to observe for any progression toward dysplasia or other complications.
Treatment Protocols: Eradication of Helicobacter pylori infection if present Managing acid reflux with appropriate medications, such as proton pump inhibitors Lifestyle modifications including quitting smoking, reducing alcohol intake, and dietary changes Regular surveillance endoscopies to monitor for any progression toward dysplasia or gastric cancer Addressing any additional risk factors identified during evaluation
Clinical Advice & FAQs
Billing Guidance
Is K31.A14 a billable ICD-10 code?
Yes, K31.A14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.A14?
Clinical documentation must specify the nature of Gastric intestinal metaplasia without dysplasia, involving the cardia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference